Department of Pathology, Veterans Affairs Medical Center, Washington, DC.
University of Louisville School of Medicine, Louisville, KY; and.
Am J Dermatopathol. 2022 Dec 1;44(12):958-960. doi: 10.1097/DAD.0000000000002292. Epub 2022 Sep 7.
Neurothekeoma, a lesion of possible fibrohistiocytic origin, is a rare, benign, superficial soft tissue tumor, histologically subclassified in 3 types: myxoid, cellular, or mixed. It clinically presents as a solitary, pink to brown nodule, ranging from 0.3 to 2.0 cm. Four point mutations (PI3K w552*, ALK P1469S, SMO G461S, and ERBB3 L77M) were identified by next-generation sequencing of a neurothekeoma presenting in the left inner thigh of a 53-year-old man. We highlight novel genetic alterations (SMO G461S and ERBB3 L77M) and previously known mutations (PI3KCA w552* and ALK P1469S) that play a role in other pathogenic pathways, but to the best of our knowledge, these have not yet been reported in neurothekeoma.
神经鞘瘤可能起源于纤维组织细胞,是一种罕见的良性、表浅软组织肿瘤,组织学上分为 3 种类型:黏液样型、细胞型或混合型。临床上表现为单发的粉红色至棕色小结节,直径 0.3~2.0cm。我们通过对一名 53 岁男性左大腿内的神经鞘瘤进行下一代测序,鉴定出 4 种点突变(PI3K w552*、ALK P1469S、SMO G461S 和 ERBB3 L77M)。我们强调了新的遗传改变(SMO G461S 和 ERBB3 L77M)和先前已知的突变(PI3KCA w552*和 ALK P1469S),这些突变在其他致病途径中起作用,但据我们所知,这些突变尚未在神经鞘瘤中报道。